Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs

por Nwabufo, Chukwunonso K., Bendayan, Reina
Publicado 2022

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease

por Nwabufo, Chukwunonso K., Aigbogun, Omozojie P.
Publicado 2022

SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues

por Nwabufo, Chukwunonso K., Hoque, Md. Tozammel, Yip, Lily, Khara, Maliha, Mubareka, Samira, Pollanen, Michael S., Bendayan, Reina
Publicado 2023